Novel API Coated Catheter Removes Amyloid-β from Plasma of Patients with Alzheimer’s Disease
Open Access
- 30 October 2021
- journal article
- Published by Herald Scholarly Open Access in Journal of Alzheimer’s & Neurodegenerative Diseases
- Vol. 7 (1), 1-7
- https://doi.org/10.24966/and-9608/100055
Abstract
The Amytrapper matrix and the novel Amytrapper catheter were able to bind and retain spiked bio-A?42 from human sera or native A? from plasma of AD patients. Additional characteristics of the Amytrapper catheter are evaluated and presented in this study.Keywords
This publication has 25 references indexed in Scilit:
- Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibodyAlzheimer's Research & Therapy, 2016
- The amyloid hypothesis of Alzheimer's disease at 25 yearsEMBO Molecular Medicine, 2016
- A prospective study on blood Aβ levels and the cognitive function of patients with hemodialysis: a potential therapeutic strategy for Alzheimer’s diseaseJournal of Neural Transmission, 2015
- Brush‐Like Polycarbonates Containing Dopamine, Cations, and PEG Providing a Broad‐Spectrum, Antibacterial, and Antifouling Surface via One‐Step CoatingAdvanced Materials, 2014
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's DiseaseThe New England Journal of Medicine, 2014
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's DiseaseThe New England Journal of Medicine, 2014
- Alzheimer’s disease drug-development pipeline: few candidates, frequent failuresAlzheimer's Research & Therapy, 2014
- LDL-Apheresis: Technical and Clinical AspectsThe Scientific World Journal, 2012
- A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivoBlood, 2009
- Amyloid-targeted therapeutics in Alzheimer's disease: Use of human albumin in plasma exchange as a novel approach for abeta mobilizationDrug News & Perspectives, 2009